ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Terray Therapeutics says the venture capital arm of the semiconductor maker Nvidia is a participant in a new round of financing. Terray isn’t disclosing the amount it raised, but it launched in early 2022 with $60 million for its iterative approach to small-molecule drug discovery. Nvidia has become one of the world’s most valuable companies on the strength of its computer chips, used by generative AI, and its cloud platform, which Terray plans to use for chemical modeling.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter